The Global Bioreactors Market Size accounted for USD 2.3 Billion in 2021 and is projected to occupy a market size of USD 6.5 Billion by 2030 growing at a CAGR of 12.4% from 2022 to 2030.
Bioreactor or fermenter is essential hardware required for bio processing. Bioreactors are explicitly developed systems or vessels that can bolster an organically live condition, as a particular encompassing is required for the cells to develop. The bioreactors by and large are accessible in the range from liters to cubic meters. Bioreactors utilized for expansive scale Cellion of therapeutics are typically made of stainless steel. Small glass bioreactors are regularly utilized for procedure advancement scale up and look into work in the biopharmaceutical segment. Single-use bioreactor, or dispensable bioreactor, has been discovering all the more wide assembling and research use. Bioreactors can execute as sustained clump, continuous mixed tank or bunch reactor frameworks.
Bioreactors Market Report Statistics
- Global bioreactors market revenue is projected to reach USD 6.5 Billion by 2030 with a CAGR of 12.4% from 2022 to 2030
- North America bioreactors market share generated over 42% shares in 2021
- Asia-Pacific bioreactors market growth will record noteworthy CAGR of over 14% from 2022 to 2030
- Based on cell, mammalian cells recorded USD 1.75 billion revenue in 2021
- Among end-use, biopharma manufacturers sub-segment accounted for USD 989 million in 2021
- Increasing R&D for novel product development is a popular bioreactors market trend that fuels the industry demand
Global Bioreactors Market Dynamics
Market Drivers
- Growing demand for monoclonal antibiotics
- Rising demand for single-use bioreactors
- Technological advancement in bioreactors
Market Restraints
- High cost associated with bioreactors
- Concerns related to extractable
Market Opportunities
- Increasing emphasis on orphan drug development
- Growing pharma and biotech industries
Bioreactors Market Report Coverage
| Market |
Bioreactors Market |
| Bioreactors Market Size 2021 |
USD 2.3 Billion |
| Bioreactors Market Forecast 2030 |
USD 6.5 Billion |
| Bioreactors Market CAGR During 2022 - 2030 |
12.4% |
| Bioreactors Market Analysis Period |
2018 - 2030 |
| Bioreactors Market Base Year |
2021 |
| Bioreactors Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Cell, By Molecule, By Product Type, By Usage, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Danaher Corporation, Merck Group, Thermo Fisher Scientific, Solaris Biotech Solutions, GE Healthcare, Sartorius, Eppendorf, Infors HT, Merck Millipore, Getinge, and others.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Bioreactors Market Growth Factors
The main considerations driving the development of the worldwide bioreactors market are the ascent in acknowledgment of single-use innovations, expanding biologics, use hybrid technologies, for example, tempered steel and single-use, and the expanding demand for the single-use bioreactor in biopharmaceutical organizations. Different variables boosting the development of the worldwide market are low useful esteem combined with a base support and observing in respect with customary ones. Also, rising unending malady occurrence and developing exploration in the field of biopharmaceuticals will drive the worldwide bioreactor market size. Expanded focal point of biopharmaceutical organizations to create compelling treatment alternatives for the most vagrant illnesses should fuel industry development.
Bioreactors Market Segmentation
The global bioreactors Market is segmented based on cell, molecule, product type, usage, end-use, and geography.
Bioreactors Market By Cell
- Mammalian Cells
- Yeast Cells
- Bacterial Cells
- Others
According to our bioreactor industry analysis, the mammalian cells sub-segment held over 76% of the market share in 2021 and is likely to continue this trend in the forthcoming years. The widespread use of mammalian cells in the development and commercialization of viral vaccines and therapeutic proteins, among other biopharmaceuticals, will drive demand for bioreactors.
Bioreactors Market By Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
According to our bioreactors market forecast, vaccines are expected to hold significant market share from 2022 to 2030. The rising prevalence of various chronic infectious diseases will fuel R&D activities for vaccine development, accelerating industry demand. Furthermore, the high prevalence of the COVID-19 virus has accelerated vaccine research and development efforts around the world, stimulating market growth.
Bioreactors Market By Product Type
Based on product type, the single-use bioreactors occupied maximum market share in 2021 and is likely to do so in the coming years. The significant market share in the segment is attributed to an increase in demand for biologic drugs, government initiatives for the development of the pharmaceutical sector, and advancement in R&D activities for vaccine production.
Bioreactors Market By Usage
- Developmental, Pre-clinical & Clinical
- Commercial Production
By usage, developmental, preclinical & clinical sub-segment achieved a considerable market share and will continue to gather more market share in the coming future. On the other hand, commercial production sub-segment is anticipated to attain a quick growth during the forecast timeframe from 2022 to 2030.
Bioreactors Market By End-Use
- R&D Organizations
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
The end-use segment is dominated by the biopharmaceutical manufacturers. The significant market share in the segment is attributed to an increase in demand for biologic drugs, government initiatives for the development of the pharmaceutical sector, and advancement in R&D activities for vaccine production. R&D organizations will grow with an impressive rate throughout the forecast period.
Bioreactors Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Bioreactors Market Regional Analysis
North America and Europe are thought to be the ruling regions in the worldwide bioreactor market because of the presence of major biopharmaceutical fabricating organizations. Asia Pacific is foreseen to develop essentially in the near future inferable from the enormous consumption conceded to the makers of biologics. Latin America is likewise expected to develop significantly in the worldwide market the same number of biopharmaceutical organizations are anticipating starting manufacturing units in this locale.
Bioreactors Market Players
The global Bioreactor market is characterized by the presence of experienced and established players. Some of the key players include Danaher Corporation, Merck Group, Thermo Fisher Scientific, Solaris Biotech Solutions, GE Healthcare, Sartorius, Eppendorf, Infors HT, Merck Millipore, Getinge, and others.
CHAPTER 1. Industry Overview of Bioreactors Market
1.1. Definition and Scope
1.1.1. Definition of Bioreactor
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Bioreactors Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Bioreactors Market By Cell
1.2.3. Bioreactors Market By Molecule
1.2.4. Bioreactors Market By Product Type
1.2.5. Bioreactors Market By Usage
1.2.6. Bioreactors Market By End-Use
1.2.7. Bioreactors Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Bioreactors Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Bioreactors Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Bioreactors Market By Cell
5.1. Introduction
5.2. Bioreactors Market Revenue By Cell
5.2.1. Bioreactors Market Revenue (USD Billion) and Forecast, By Cell, 2018-2030
5.2.2. Mammalian Cells
5.2.2.1. Mammalian Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Yeast Cells
5.2.3.1. Yeast Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Bacterial Cells
5.2.4.1. Bacterial Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Bioreactors Market By Molecule
6.1. Introduction
6.2. Bioreactors Market Revenue By Molecule
6.2.1. Bioreactors Market Revenue (USD Billion) and Forecast, By Molecule, 2018-2030
6.2.2. Monoclonal Antibodies
6.2.2.1. Monoclonal Antibodies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Vaccines
6.2.3.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Recombinant Proteins
6.2.4.1. Recombinant Proteins Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Stem Cells
6.2.5.1. Stem Cells Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.6. Gene Therapy
6.2.6.1. Gene Therapy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Bioreactors Market By Product Type
7.1. Introduction
7.2. Bioreactors Market Revenue By Product Type
7.2.1. Bioreactors Market Revenue (USD Billion) and Forecast, By Product Type, 2018-2030
7.2.2. Single-Use
7.2.2.1. Single-Use Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Reusable
7.2.3.1. Reusable Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Bioreactors Market By Usage
8.1. Introduction
8.2. Bioreactors Market Revenue By Usage
8.2.1. Bioreactors Market Revenue (USD Billion) and Forecast, By Usage, 2018-2030
8.2.2. Developmental, Pre-clinical & Clinical
8.2.2.1. Developmental, Pre-clinical & Clinical Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Commercial Production
8.2.3.1. Commercial Production Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. Bioreactors Market By End-Use
9.1. Introduction
9.2. Bioreactors Market Revenue By End-Use
9.2.1. Bioreactors Market Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
9.2.2. R&D Organizations
9.2.2.1. R&D Organizations Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.3. Biopharmaceutical Manufacturers
9.2.3.1. Biopharmaceutical Manufacturers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
9.2.4. Contract Manufacturing Organizations (CMOs)
9.2.4.1. Contract Manufacturing Organizations (CMOs) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 10. North America Bioreactors Market By Country
10.1. North America Bioreactors Market Overview
10.2. U.S.
10.2.1. U.S. Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
10.2.2. U.S. Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
10.2.3. U.S. Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
10.2.4. U.S. Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
10.2.5. U.S. Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Canada
10.3.1. Canada Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
10.3.2. Canada Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
10.3.3. Canada Bioreactors Market Revenue (USD Billion) and Forecast By Product Type , 2018-2030
10.3.4. Canada Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
10.3.5. Canada Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. North America PEST Analysis
CHAPTER 11. Europe Bioreactors Market By Country
11.1. Europe Bioreactors Market Overview
11.2. U.K.
11.2.1. U.K. Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
11.2.2. U.K. Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
11.2.3. U.K. Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.2.4. U.K. Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
11.2.5. U.K. Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Germany
11.3.1. Germany Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
11.3.2. Germany Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
11.3.3. Germany Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.3.4. Germany Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
11.3.5. Germany Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. France
11.4.1. France Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
11.4.2. France Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
11.4.3. France Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.4.4. France Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
11.4.5. France Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Spain
11.5.1. Spain Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
11.5.2. Spain Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
11.5.3. Spain Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.5.4. Spain Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
11.5.5. Spain Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.6. Rest of Europe
11.6.1. Rest of Europe Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
11.6.2. Rest of Europe Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
11.6.3. Rest of Europe Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
11.6.4. Rest of Europe Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
11.6.5. Rest of Europe Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.7. Europe PEST Analysis
CHAPTER 12. Asia-Pacific Bioreactors Market By Country
12.1. Asia-Pacific Bioreactors Market Overview
12.2. China
12.2.1. China Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.2.2. China Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.2.3. China Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.2.4. China Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.2.5. China Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. Japan
12.3.1. Japan Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.3.2. Japan Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.3.3. Japan Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.3.4. Japan Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.3.5. Japan Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. India
12.4.1. India Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.4.2. India Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.4.3. India Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.4.4. India Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.4.5. India Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Australia
12.5.1. Australia Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.5.2. Australia Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.5.3. Australia Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.5.4. Australia Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.5.5. Australia Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.6. South Korea
12.6.1. South Korea Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.6.2. South Korea Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.6.3. South Korea Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.6.4. South Korea Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.6.5. South Korea Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.7. Rest of Asia-Pacific
12.7.1. Rest of Asia-Pacific Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
12.7.2. Rest of Asia-Pacific Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
12.7.3. Rest of Asia-Pacific Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
12.7.4. Rest of Asia-Pacific Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
12.7.5. Rest of Asia-Pacific Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.8. Asia-Pacific PEST Analysis
CHAPTER 13. Latin America Bioreactors Market By Country
13.1. Latin America Bioreactors Market Overview
13.2. Brazil
13.2.1. Brazil Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
13.2.2. Brazil Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
13.2.3. Brazil Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.2.4. Brazil Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
13.2.5. Brazil Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.3. Mexico
13.3.1. Mexico Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
13.3.2. Mexico Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
13.3.3. Mexico Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.3.4. Mexico Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
13.3.5. Mexico Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.4. Rest of Latin America
13.4.1. Rest of Latin America Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
13.4.2. Rest of Latin America Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
13.4.3. Rest of Latin America Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
13.4.4. Rest of Latin America Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
13.4.5. Rest of Latin America Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.5. Latin America PEST Analysis
CHAPTER 14. Middle East & Africa Bioreactors Market By Country
14.1. Middle East & Africa Bioreactors Market Overview
14.2. GCC
14.2.1. GCC Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
14.2.2. GCC Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
14.2.3. GCC Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.2.4. GCC Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
14.2.5. GCC Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
14.3. South Africa
14.3.1. South Africa Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
14.3.2. South Africa Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
14.3.3. South Africa Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.3.4. South Africa Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
14.3.5. South Africa Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
14.4. Rest of Middle East & Africa
14.4.1. Rest of Middle East & Africa Bioreactors Market Revenue (USD Billion) and Forecast By Cell, 2018-2030
14.4.2. Rest of Middle East & Africa Bioreactors Market Revenue (USD Billion) and Forecast By Molecule, 2018-2030
14.4.3. Rest of Middle East & Africa Bioreactors Market Revenue (USD Billion) and Forecast By Product Type, 2018-2030
14.4.4. Rest of Middle East & Africa Bioreactors Market Revenue (USD Billion) and Forecast By Usage, 2018-2030
14.4.5. Rest of Middle East & Africa Bioreactors Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
14.5. Middle East & Africa PEST Analysis
CHAPTER 15. Player Analysis Of Bioreactors Market
15.1. Bioreactors Market Company Share Analysis
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
15.2.2. New Cell Launches and Cell Enhancements
15.2.3. Mergers And Acquisition In Global Bioreactors Market
15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 16. Company Profile
16.1. Danaher Corporation
16.1.1. Company Snapshot
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.3.1. Revenue (USD Billion), 2021
16.1.3.2. Danaher Corporation 2021 Bioreactor Business Regional Distribution
16.1.4. Cell /Service and Specification
16.1.5. Recent Developments & Business Strategy
16.2. Merck Group
16.3. Thermo Fisher Scientific
16.4. Solaris Biotech Solutions
16.5. GE Healthcare
16.6. Sartorius
16.7. Eppendorf
16.8. Infors HT
16.9. Merck Millipore
16.10. Getinge
